Key facts
- It has raised $7.2M; the latest was Seed Round ($5.0M) in May 2025.
- Notable investors include MedTech Innovator, Everywhere Ventures, Polsky Center for Entrepreneurship and Innovation at the University of Chicago, University of Chicago Medical Center Endowment, George Shultz Innovation Fund — 10 tracked in total.
- Status: Privately Held (backing).
Investors
10- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Flow Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Flow Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Flow Medical
Developer of a thrombolysis catheter designed to treat pulmonary embolism. The company's catheter helps to improve clot visualization, deliver clot-dissolving medication directly to the blockage and monitor treatment progress in real-time, enabling clinicians to personalize therapy for each patient.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2020
- Employees
- 6
- Website
- flowmedical.co/
- Ownership
- Privately Held (backing)
Flow Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Flow Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Flow Medical in its N-PORT filings yet. We sweep new filings monthly.